That's quite the question.
There are already provisions within the Competition Act addressing components of what you just noted. Beyond the general redundancies that exist with the passage of Bill C-59, I would simply reiterate our existing concerns in addition to its redundancies.
However, when it comes to the U.S., of course there are regulations regarding claims there that must be appropriately measured. We do see a number of countries globally regulating front-of-package labelling and different claims that are made, and those are benchmarked to international standards.
Again, it's not that anyone at this committee is concerned about the attestation or verifiability. It's simply the lack of clarity within the proposed legislation and within past legislation. We're simply requesting that clarity.